Bank of America’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,000
Closed -$615K 7907
2023
Q2
$615K Buy
+9,000
New +$580K ﹤0.01% 5127
2021
Q2
Sell
-70,000
Closed -$1.76M 8006
2021
Q1
$1.76M Buy
+70,000
New +$1.32M ﹤0.01% 4372
2018
Q4
Sell
-989,600
Closed -$12.9M 7323
2018
Q3
$12.9M Buy
+989,600
New +$14.3M ﹤0.01% 2212
2018
Q1
Sell
-500
Closed -$19K 7287
2017
Q4
$19K Buy
+500
New +$25.5K ﹤0.01% 6430
2014
Q4
Sell
-38,900
Closed -$862K 7887
2014
Q3
$862K Sell
38,900
-1,100
-3% -$23.3K ﹤0.01% 4107
2014
Q2
$902K Buy
+40,000
New +$1M ﹤0.01% 4076

Other funds holding PRTA

Bank of America's PRTA Position: Q1 2026 in Review

Bank of America reduced its Prothena Corp (PRTA) stake by 7.9% in Q1 2026, selling an estimated $309K and leaving 393,632 shares worth $3.83M. The position accounts for ﹤0.01% of the portfolio, ranked #3660.

Bank of America first reported a position in PRTA in Q2 2013 and has held it in 52 quarters since. The position peaked at $37.3M in Q2 2014. 185 funds tracked by Wall St. Rank hold PRTA as of Q1 2026.

  • Bank of America held 393,632 shares of Prothena Corp worth $3.83M as of Q1 2026.
  • Bank of America sold 33,728 Prothena Corp shares in Q1 2026, an estimated $309K.
  • Prothena Corp made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3660 holding.
  • Bank of America first reported a position in Prothena Corp in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Prothena Corp position peaked at $37.3M in Q2 2014.
  • 185 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.